{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:54:00Z","timestamp":1769885640548,"version":"3.49.0"},"reference-count":27,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2026,1,25]]},"DOI":"10.23922\/jarc.2025-065","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T22:09:31Z","timestamp":1769292571000},"page":"19-25","source":"Crossref","is-referenced-by-count":0,"title":["Pathological Response of Locally Recurrent Rectal Cancer to Neoadjuvant Chemoradiotherapy"],"prefix":"10.23922","volume":"10","author":[{"given":"Yuichiro","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Nozawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Murono","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenobu","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahide","family":"Shinagawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006 Sep;355 (11):1114-23.","DOI":"10.1056\/NEJMoa060829"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wanebo HJ, Koness RJ, Vezeridis MP, et al. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994 Oct;220 (4):586-95.","DOI":"10.1097\/00000658-199410000-00017"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ogunbiyi OA, McKenna K, Birnbaum EH, et al. Aggressive surgical management of recurrent rectal cancer--is it worthwhile? Dis Colon Rectum. 1997 Feb;40 (2):150-5.","DOI":"10.1007\/BF02054979"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bhangu A, Ali SM, Darzi A, et al. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis. 2012 Dec;14 (12):1457-66.","DOI":"10.1111\/j.1463-1318.2012.03005.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Vermaas M, Ferenschild FT, Nuyttens JJ, et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum. 2005 May;48 (5):918-28.","DOI":"10.1007\/s10350-004-0891-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lowy AM, Rich TA, Skibber JM, et al. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma. Ann Surg. 1996 Feb;223 (2):177-85.","DOI":"10.1097\/00000658-199602000-00010"},{"key":"7","unstructured":"7. Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013 Jul;100 (8):1009-14."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fadel MG, Ahmed M, Malietzis G, et al. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: a systematic review. Cancer Treat Rev. 2022 Sep;109:102419.","DOI":"10.1016\/j.ctrv.2022.102419"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Moriya Y, Akasu T, Fujita S, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum. 2004 Dec;47 (12):2047-53.","DOI":"10.1007\/s10350-004-0714-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum. 2008 Mar;51 (3):284-91.","DOI":"10.1007\/s10350-007-9152-9"},{"key":"11","unstructured":"11. PelvEx Collaborative. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer. Br J Surg. 2018 May;105 (6):650-7."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yu SKT, Bhangu A, Tait DM, et al. Chemoradiotherapy response in recurrent rectal cancer. Cancer Med. 2014 Feb;3 (1):111-7.","DOI":"10.1002\/cam4.169"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ozaki K, Kawai K, Nozawa H, et al. Development of a novel apoptosis-based tumor regression grade to assess the efficacy of preoperative chemoradiotherapy for rectal cancer: a retrospective single-center study. Int J Clin Oncol. 2021 Sep;26 (9):1679-88.","DOI":"10.1007\/s10147-021-01948-2"},{"key":"14","unstructured":"14. Sobin LH, Gospodarowicz MK, Wittekind C (eds). TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell, Oxford, 2017."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wo JY, Anker CJ, Ashman JB, et al. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2021 Jan-Feb;11 (1):13-25.","DOI":"10.1016\/j.prro.2020.08.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lefevre JH, Mineur L, Kotti S, et al. Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6). J Clin Oncol. 2016 Nov 1;34 (31):3773-80.","DOI":"10.1200\/JCO.2016.67.6049"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. J Anus Rectum Colon. 2019 Oct;3 (4):175-95.","DOI":"10.23922\/jarc.2019-018"},{"key":"18","unstructured":"18. Yokoyama Y, Ishihara S. Neoadjuvant chemoradiotherapy for locally recurrent rectal cancer. Operation. 2025 May;79 (6):897-903. Japanese."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ulintz PJ, Greenson JK, Wu R, et al. Lymph node metastases in colon cancer are polyclonal. Clin Cancer Res. 2018 May;24 (9):2214-24.","DOI":"10.1158\/1078-0432.CCR-17-1425"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kamran SC, Lennerz JK, Margolis CA, et al. Integrative molecular characterization of resistance to neoadjuvant chemoradiation in rectal cancer. Clin Cancer Res. 2019 Sep;25 (18):5561-71.","DOI":"10.1158\/1078-0432.CCR-19-0908"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Xu L, Cai S, Xiao T, et al. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study. Colorectal Dis. 2017 Jul;19 (7):263-71.","DOI":"10.1111\/codi.13757"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Nagtegaal ID, Glynne-Jones R. How to measure tumour response in rectal cancer? An explanation of discrepancies and suggestions for improvement. Cancer Treat Rev. 2020 Mar:84:101964.","DOI":"10.1016\/j.ctrv.2020.101964"},{"key":"23","unstructured":"23. Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jan;22 (1):29-42."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Conroy T, Castan F, Etienne PL, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024 Oct;35 (10):873-81.","DOI":"10.1016\/j.annonc.2024.06.019"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nordkamp S, Piqeur F, van den Berg K, et al. Locally recurrent rectal cancer: oncological outcomes for patients with a pathological complete response after neoadjuvant therapy. Br J Surg. 2023 Jul;17;110 (8):950-7.","DOI":"10.1093\/bjs\/znad094"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Denost Q, Frison E, Salut C, et al; on behalf the GRECCAR Group. A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocol. Colorectal Dis. 2021 Jul;23 (7):1909-18.","DOI":"10.1111\/codi.15670"},{"key":"27","unstructured":"27. PelvEx Collaborative. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II). BJS Open. 2021 May;5 (3):zrab029."}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/1\/10_2025-065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:38:33Z","timestamp":1769834313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/1\/10_2025-065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2025-065","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"article-number":"2025-065"}}